| Tag | Content |
|---|
EnhancerAtlas ID | HS116-14569 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr17:26311340-26313370 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr17:26311723-26311744 | AAAGGAAAAAAGAAAGAAGAT | - | 6.03 | | RREB1 | MA0073.1 | chr17:26311646-26311666 | CCCCCCCGCACCCCCCCCCC | + | 6.73 | | ZNF740 | MA0753.2 | chr17:26311656-26311669 | CCCCCCCCCCCCC | + | 6.03 | | ZNF740 | MA0753.2 | chr17:26311657-26311670 | CCCCCCCCCCCCC | + | 6.03 | | ZNF740 | MA0753.2 | chr17:26311658-26311671 | CCCCCCCCCCCCC | + | 6.03 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_08349 | chr17:26311217-26313417 | Brain_Inferior_Temporal_Lobe | | SE_63325 | chr17:26281981-26324050 | NCI-H82 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I027984 | chr17 | 26311523 | 26314933 |
|
Enhancer Sequence | TTTATACGTA TTTCCCCAGG CACATCCCTG AAAAACCAGT ATATACTCAG ACATTCCCTT 60
GAATCAAAAT CGAGTCTATT CCACTTCCTC CTCAGTCCAG TGAGGTGTTC AAGACATCAA 120
TTATTATCCC CATTTTAGAC ATCAGGACCC CAAGGGACTT AGCAGCATCT AAGTAGCCTG 180
CTCAAAGATT CAAGGCTAAT CCAATGTCCT CCGTACTCTT TTCTTAGCCT TCCTGACAAT 240
TTGTGTTCAC TGCCCCCTCT AATTCTCTGT CCAAGCTAAA AGACCGTGAA TTCCACACAC 300
ACACCTCCCC CCCGCACCCC CCCCCCCCCC CGGCTGCCGG CAAATGCAGC CTGATTATCG 360
GAAGGAGATG CCTGAGAAGA GTGAAAGGAA AAAAGAAAGA AGATAGAGGG AGATGGGGTA 420
AAGGGACATG TGGCCTCGTT CTTCACTGTC CCAAATTCCC TTTTCAAGGG CATAAGCCTG 480
CACCCACCTC TTCCAACCGC CCCCTCCATC CTTGTCTCTG CCCCTGTGTC CCTGTCTTGT 540
CCTCCCAAGG GCTACAGCAA TATTTCAAAT GTTCCTCCCA CAGCTGGGTG CCTGCGCTGG 600
TTTCTGGGCT CCTGGCATCC TGAAGCCCCA CCCTGATGCT GGCTCCACAC GTGCCTGTGC 660
ACATTCAGGG CTGTGAAGGG TCAGTGGGCC ACGTGAAATT CCAGGAAGGA ACAAGGCTTC 720
AGGGGTGCTG TCCTTGGCTG GTTCCTACAG CACTTCCTTC CTTGTACCCC GCAGAGCCTT 780
TGGCATGTAG AGTCACGTGT TCATCTAAGT ACCACTGATG GTTTTGATTT TCTACCTGAA 840
GAGTGCACAG AAGCTGGCCT TGGACAATAA AAGCAAAGGC AAAGGTGCCC GGAAGGAAGG 900
ATCAGTGTGA GGAGGGTATG GAATGGTGCA TGCAAAGTAC CAGCACAGCG CCTGGCACAG 960
TGTAGACTCC TCACACAGAG GGCTCTCCTC CCTGCCCCCA AGGAGATCTC AGAGGCCCCC 1020
CTCCTGCCAA AGCGGCATTT CAACTCCTCG CATACACTTG GGCTTCAGTC CATTACACAA 1080
GGAAATTTGG CTTCATTTAT ATAAAGGGGC TAATTACCAC ATGAGACATA ATTACAAGAC 1140
AGGAAATGGA TTTATAGATG CCGTCAGTGG GAGGGGAAGT TGCAGCGGCT GCTTGGACTG 1200
CTCCGTGCTC CTAAGGGGCT AAAGCTGTCC CCAGCGGACA GGATTCTTGC CCTGGGAGTT 1260
CTTGCTTTGC TGAGAAATGT GCTCTTAGAG AGGTCGGCAG TACTACAGAT TTCTGGAAAT 1320
CAAATCTAGT TCTGTCTCTG AATTTGTTCC ACAATTGGCA ATGTATTCCC ACAGGTTCTC 1380
TTCACACAAT AAAAATCATA CTTAAGAATG TAGTTAGTCT TAAACATTAA AAGAGAAAGA 1440
TAAGTCTTAT GATAGATTCC AAAACTAGCC CAAAGGAGAA ATGCTGGGTA GAAACTGTAC 1500
AGCACTAGTA TCTGCTCTTC TTTGAGGTTA GATGAACCCT GAGAAAGAGC TATATTTGCC 1560
AGACACGGTG GTGTGCACCT GTAGTCTCAG CTACTTAGGG GGCTGATCGC TTGAGCTGAG 1620
GCATTCAAGG CCAGCCTGGG CAGCACCCTT TCTAAAAGGG GGGAAAAAGA GCTATATGCC 1680
TGCTAATTGA CCTAATAAAT AGTCCCTTAT GATTTCATTT TTCACCTTAA AACCATATAT 1740
CTTAATTTAG ACACACATAC ACACACAGAA ACAGACAATA GGCAGAAGTG AAAAGGCCCT 1800
TCCTCATTGA TAACCAAAGA TAAGCAAATT AGTACTAGCT AATATGTGGG GAGCACACTC 1860
TGTGCCAAGC ACTGAGCTTT GCTGTCTTAT TTGTTCATCT TCACAACAGT CCCATGAGGA 1920
GGGTGCAGTC ATAATCCTCA ATTGATAGCT AAGGAACTGA GACTTAGGAA GGTCAACCAA 1980
GGTGGCCAAG TCCATACTGT AAATGCCAGA ACAAGCGTTT GCACACCACT 2030
|
